Evidence map›Paper›PMID 37310410›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

A Photomodulable Bacteriophage-Spike Nanozyme Enables Dually Enhanced Biofilm Penetration and Bacterial Capture for Photothermal-Boosted Catalytic Therapy of MRSA Infections.

Haibin Wu, Min Wei, Shen Hu, Pu Cheng, Shuhan Shi, Fan Xia, Lenan Xu, Lina Yin, Guang Liang, Fangyuan Li and 1 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
8.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Multi-Dimensional Synergistic Engineering for Boosting Nanozyme Catalysis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Haibin WuSchool of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, 311399, P. R. China.
Min WeiInstitute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, P. R. China.
Shen HuDepartment of Obstetrics and Gynaecology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, P. R. China.
Pu ChengDepartment of Obstetrics and Gynaecology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, P. R. China.
Shuhan ShiSchool of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, 311399, P. R. China.
Fan XiaInstitute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, P. R. China.
Lenan XuSchool of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, 311399, P. R. China.
Lina YinSchool of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, 311399, P. R. China.
Guang LiangSchool of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, 311399, P. R. China.
Fangyuan LiInstitute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, P. R. China.
Daishun LingInstitute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310012, P. R. China.ORCID 0000-0002-9977-0237
Hangzhou Medical College · CNSecond Affiliated Hospital of Zhejiang University · CNUnivates · BRZhejiang University · CN

Funding

Basic Scientific Research Funds of Department of Education of Zhejiang Province KYZD202205CAS Interdisciplinary Innovation Team JCTD-2020-08Explorer Program of Science and Technology Commission of Shanghai Municipality 22TS1400700Hangzhou Medical College Qiuzhen Talent Project 00004F1RCYJ2209Health Bureau of Zhejiang Province/General Program 2021438429Innovative Research Team of High-Level Local Universities in Shanghai SHSMU-ZDCX20210900National Key Research and Development Program of China 2022YFB3203800National Key Research and Development Program of China 2022YFB3203801National Key Research and Development Program of China 2022YFB3203804National Natural Science Foundation of China 32071374National Natural Science Foundation of China 32201161Program of Shanghai Academic Research Leader under the Science and Technology Innovation 21XD1422100Zhejiang Provincial Key Scientific Project 2021C03041Zhejiang Provincial Natural Science Foundation of China GF22H168862Zhejiang Provincial Natural Science Foundation of China LQ21H300004Zhejiang Provincial Natural Science Foundation of China LR22C100001Zhejiang Traditional Chinese Medicine Science and Technology Program 2023ZF122
6 · The paper itself

Abstract

Nanozymes, featuring intrinsic biocatalytic effects and broad-spectrum antimicrobial properties, are emerging as a novel antibiotic class. However, prevailing bactericidal nanozymes face a challenging dilemma between biofilm penetration and bacterial capture capacity, significantly impeding their antibacterial efficacy. Here, this work introduces a photomodulable bactericidal nanozyme (ICG@hMnO

Indexed as

BacteriophagesBiofilmsMethicillin-Resistant Staphylococcus aureusNanoparticlesStaphylococcal InfectionsHumansLasersManganese CompoundsOxidesManganese Compoundsmanganese oxideOxidesantibacterial therapybacterial capturebiofilm penetrationnanozymenature-inspired nanostructures

Identifiers

PMID37310410
PMCPMC10460864
OpenAlexW4380422821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.